HIGHLIGHTS
- who: Min Li from the Department of Disease, Peking University First Hospital, Beijing, China have published the paper: Effect of sodium-glucose cotransporter-2 inhibitors on blood pressure in patients with heart failure: a systematic review and meta-analysis, in the Journal: (JOURNAL) of April/29,/2022
- what: In our meta-analysis of 16 randomized controlled trials of SGLT2i in patients with HF, we demonstrated that these agents significantly reduce SBP but do not have an effect on DBP.
- how: The literature search process and its results are shown in Fig 1. Key . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.